The Regulatory Review’s extensive COVID-19 global series exemplifies Penn Law’s international and cross-disciplinary strengths.
The federal government seeks to improve out-of-state health services for children on Medicaid.
FDA issues heightened standards for antibody tests, the Department of Justice announces first arrests for COVID-19 emergency lending fraud, and more…
Congress passes additional legislation to combat COVID-19, the D.C. Circuit hears oral arguments by phone, and more…
To curb overdoses and drug trafficking, the DEA proposes regulations for a chemical precursor to fentanyl.
CMS issues temporary waivers to hospitals amid the coronavirus pandemic, the Trump Administration rolls back vehicle emissions standards, and more…
Amid the coronavirus, the federal government eases restrictions on prescribing controlled substances by telehealth.
The federal government responds to the coronavirus pandemic by amending its foreign quarantine rules.
Federal regulators seek to expand safe harbors for provider care coordination arrangements.
To fight opioid misuse, the U.S. government proposes expanding access to medical records on substance use.
As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.